The Importance of Clinical Presentation in Risk and Management of Recurrent Preterm Birth

Abstract

Objective This study aimed to compare the risk of recurrent spontaneous preterm birth (sPTB), as well as cerclage efficacy, between groups stratified by phenotype of the index sPTB.

Study Design This is a retrospective cohort study of women with a history of sPTB. Included were women with a history of singleton sPTB who received progesterone in a subsequent pregnancy. Multifetal gestations and abdominal cerclage were excluded. Exposure groups were based upon the presenting symptom that preceded their first sPTB and included painless cervical dilation (PCD), preterm premature rupture of membranes (PPROM), and painful dilation (preterm labor [PTL]). Primary outcome was delivery <34 weeks in a subsequent pregnancy. Secondary outcomes included delivery <28 and <37 weeks. Rates were compared using the Chi-square test. Multivariable Poisson regression was used to adjust for confounders.

Results A total of 723 women were included. A total of 114 (16%) presented with PCD, 305 (42%) with PPROM, and 304 (42%) with PTL in their first sPTB. Cerclage in subsequent pregnancy was highest in the PCD group (42%) when compared with the PPROM (16%) and PTL (12%) groups. Rates of sPTB <34 and 37 weeks were similar among the groups. After adjusting for confounders, PCD was found to significantly increase the risk of recurrent sPTB <28 weeks (incidence rate ratio: 3.46 [1.09–11.0]; p = 0.04). Of the 121 women who underwent cerclage, there were no significant differences in rates of sPTB between the clinical presentation groups.

Conclusion PCD as a specific phenotype of sPTB impacts recurrence of delivery before 28 weeks, but not at later gestational ages. In contrast, there was no significant association between clinical presentation of index sPTB and gestational latency in women who also underwent cerclage placement in a subsequent pregnancy. Our data suggest that clinical presentation is important with regards to recurrence of early sPTB, but not sPTB at later gestational ages.

Key Points

• Phenotype is critical to understanding PTB.

• Phenotype is associated with recurrent PTB.

• Painless dilation is associated with recurrent PTB.

Keywords

preterm birth - phenotype - clinical presentation - cerclage - recurrence

Note

Poster (146) entitled “Clinical presentation of preterm birth and gestational latency after cerclage” was presented at the 39th Annual Pregnancy Meeting of the Society for Maternal-Fetal Medicine, February 14, 2019, Las Vegas, NV.

Publication History

Received: 05 March 2020

Accepted: 24 June 2020

Article published online:
20 August 2020

• References

• 1 Lockwood CJ, Kuczynski E. Risk stratification and pathological mechanisms in preterm delivery. Paediatr Perinat Epidemiol 2001; 15 (Suppl. 02) 78-89
• 2 Spong CY. Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol 2007; 110 (2 Pt 1): 405-415
• 3 Purisch SE, Gyamfi-Bannerman C. Epidemiology of preterm birth. Semin Perinatol 2017; 41 (07) 387-391
• 4 Adams MM, Elam-Evans LD, Wilson HG, Gilbertz DA. Rates of and factors associated with recurrence of preterm delivery. JAMA 2000; 283 (12) 1591-1596
• 5 American College of Obstetricians and Gynecologists. ACOG practice bulletin no.142: cerclage for the management of cervical insufficiency. Obstet Gynecol 2014; 123 (2 Pt 1): 372-379
• 6 Frey HA, Klebanoff MA. The epidemiology, etiology, and costs of preterm birth. Semin Fetal Neonatal Med 2016; 21 (02) 68-73
• 7 Kramer MS, Papageorghiou A, Culhane J. et al. Challenges in defining and classifying the preterm birth syndrome. Am J Obstet Gynecol 2012; 206 (02) 108-112
• 8 Klebanoff MA, Shiono PH. Top down, bottom up and inside out: reflections on preterm birth. Paediatr Perinat Epidemiol 1995; 9 (02) 125-129
• 9 Manuck TA, Esplin MS, Biggio J. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Genomics and Proteomics Network for Preterm Birth Research. The phenotype of spontaneous preterm birth: application of a clinical phenotyping tool. Am J Obstet Gynecol 2015; 212 (04) 487.e1-487.e11
• 10 Goldenberg RL, Gravett MG, Iams J. et al. The preterm birth syndrome: issues to consider in creating a classification system. Am J Obstet Gynecol 2012; 206 (02) 113-118
• 11 Drassinower D, Običan SG, Siddiq Z, Heller D, Gyamfi-Bannerman C, Friedman AM. Does the clinical presentation of a prior preterm birth predict risk in a subsequent pregnancy?. Am J Obstet Gynecol 2015; 213 (05) 686.e1-686.e7
• 12 Iams JD, Berghella V. Care for women with prior preterm birth. Am J Obstet Gynecol 2010; 203 (02) 89-100
• 13 Gonzalez-Quintero VH, Cordova YC, Istwan NB. et al. Influence of gestational age and reason for prior preterm birth on rates of recurrent preterm delivery. Am J Obstet Gynecol 2011; DOI: 10.1016/j.ajog.2011.06.043.
• 14 Iams JD, Cebrik D, Lynch C, Behrendt N, Das A. The rate of cervical change and the phenotype of spontaneous preterm birth. Am J Obstet Gynecol 2011; 205 (02) 130.e1-130.e6 . Doi: 10.1016/j.ajog.2011.05.021
• 15 Meis PJ, Klebanoff M, Thom E. et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348 (24) 2379-2385